Hal V. Barron
| Use attributes for filter ! | |
| Gender | Male |
|---|---|
| Field | Physician |
| Alma maters | Washington University in St. Louis |
| Yale University | |
| University of California, San Francisco | |
| Institutions | Genentech |
| Roche Holding AG | |
| University of California, San Francisco | |
| Calico | |
| Job | Cardiologist |
| Epidemiologist | |
| Education | Washington University in St. Louis |
| Yale University | |
| University of California, San Francisco | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 443888 |
Hal V. Barron Life story
Hal V. Barron is an American clinician-scientist and drug developer who will serve as president of research and development at GlaxoSmithKline from March 2018. Prior to this he served as president of research and development at Calico.
